Skip to main content

Table 1 Baseline characteristics of breast cancer cases and controls with BRCA1 and BRCA2 mutations.

From: Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Characteristic

BRCA1

BRCA2

 

Controls

(n = 1,243)

Cases

(n = 1,243)

P

Controls

(n = 422)

Cases

(n = 422)

P

Year of birth, mean (range)

1957.5 (1920-1980)

1957.3 (1920-1980)

0.71

1954.4 (1924-1978)

1955.3 (1924-1978)

0.82

Age at diagnosis, mean (range)

n/a1

0.71

n/a1

n/a1

42.7 (24-67)

n/a1

Country of residence, n (%)

      

Poland

601 (48%)

matched

 

0 (0%)

matched

 

USA

323 (26%)

  

187 (44%)

  

Canada

265 (21%)

  

218 (52%)

  

Israel

29 (2%)

  

13 (3%)

  

Austria

18 (1.5%)

  

3 (0.7%)

  

Italy

5 (0.4%)

  

0 (0%)

  

United Kingdom

2 (0.2%)

  

2 (0.5%)

  

Age at menarche, mean (range)

13.27(8-28)

13.09 (9-21)

0.003

12.64 (8-28)

12.15 (9-17)

0.88

Age at first birth, mean (range)

25.1 (15-44)

24.8 (15-42)

0.08

26.6 (17-44)

26.3 (16-42)

0.37

Age at last birth, mean (range)

29.3 (16-45)

29.0 (17-44)

0.06

30.5 (20-45)

30.2 (18-43)

0.96

Parity2,4, n (%)

      

1

235 (19%)

  

65 (15%)

  

2

663 (53%)

  

233 (55%)

  

3

280 (23%)

  

100 (24%)

  

≥ 4

65 (5%)

  

24 (6%)

  

Mean (range)

2.16 (1-6)

matched

 

2.20 (1-6)

matched

 

Breastfeeding, mean months3,4 (range)

10.4 (0-92)

8.8 (0-84)

0.0009

9.7 (0-94)

10.2 (0-86)

0.56

Oral contraceptive use4, ever, n (%)

644 (52%)

657 (53%)

0.95

348 (83.5%)

336 (80.2%)

0.22

Smoking status, ever, n (%)

549 (45%)

574 (46%)

0.74

185 (44.4%)

170 (40.9%)

0.31

Alcohol use, ever, n (%)

832 (67%)

760 (61%)

0.002

305 (73.3%)

284 (68.8%)

0.13

HRT use4, n (%)

148 (12%)

67 (5%)

< 0.0001

69 (16.5%)

45 (10.7%)

0.02

BMI at age 30, mean (range)

22.5 (13-47)

22.6 (9-62)

0.24

22.8 (15-54)

23.0 (12-65)

0.48

  1. 1n/a, not applicable. 2Parity includes live births only. 3Breastfeeding is the total months of breastfeeding for each pregnancy combined. 4Parity, breastfeeding, oral contraceptive use and HRT use were censored one year prior to the diagnosis of the matched case for both cases and controls.